Investing in innovative Biopharma Assets in Emerging Markets

At Rezk Ventures, we prioritize assets with the potential to transform healthcare ecosystems in emerging markets. Our focus is on innovative therapies and solutions that address unmet medical needs, disrupt monopolized markets, and create sustainable value for global health.

We actively seek assets in vaccines, blood products, rare diseases, and biosimilars, with an emphasis on next-generation technologies and affordable innovation.

1. High Impact Potential: These therapies target diseases with significant unmet needs, ensuring maximum health benefits.
2. Market Disruption: Innovative and affordable products challenge monopolized markets, improving accessibility for patients.
3. Strategic Value: Each investment aligns with the foundation’s mission to balance profitability with global healthcare impact.

Focus Areas Include:

• High Valency PCV (>20): Broader pneumococcal serotype coverage to enhance disease prevention.

• High Valency HPV (>9): Extended protection against multiple HPV strains to prevent cervical cancer and related diseases.

• RSV Vaccines: Innovative solutions to combat respiratory syncytial virus in vulnerable populations, particularly infants and the elderly.

• Shingles Recombinant Vaccines: Advanced recombinant formulations targeting broader and more effective protection for aging populations.

• Rotavirus Vaccines: Next-generation vaccines to address pediatric gastroenteritis, particularly in regions with high child mortality rates.

Focus Areas Include:

• Immunoglobulins: For treating immune deficiencies in regions with high unmet needs.

• Clotting Factors: Affordable treatments for hemophilia and other bleeding disorders.

• Genetic Blood Products: Novel therapies for inherited blood disorders like sickle cell disease and thalassemia.

• Enzyme Replacement Therapies: Innovative solutions for lysosomal storage disorders like Gaucher and Fabry diseases.

• Gene Therapies: Cutting-edge approaches to inherited disorders, offering long-term solutions.

• Therapies for Genetic Diseases: New treatments for disorders such as cystic fibrosis, Huntington’s disease, and other hereditary conditions.